Oak Ridge National Laboratory, Neutron Scattering Division, Oak Ridge, TN 37831, USA.
Medicina (Kaunas). 2021 Dec 9;57(12):1343. doi: 10.3390/medicina57121343.
: As an mRNA-based vaccine, the Pfizer-BioNTech COVID-19 vaccine has stringent cold storage requirements to preserve functionality of the mRNA active ingredient. To this end, lipid components of the vaccine formulation play an important role in stabilizing and protecting the mRNA molecule for long-term storage. The purpose of the current study was to measure molecular-level dynamics as a function of temperature in the Pfizer-BioNTech COVID-19 vaccine to gain microscopic insight into its thermal stability. : We used quasielastic and inelastic neutron scattering to probe (1) the vaccine extracted from the manufacturer-supplied vials and (2) unperturbed vaccine in the original manufacturer-supplied vials. The latter measurement was possible due to the high penetrative power of neutrons. : Upon warming from the low-temperature frozen state, the vaccine in its original form exhibits two-step melting, indicative of a two-phase morphology. Once the melting is completed (above 0 °C), vaccine re-freezing cannot restore its original two-phase state. This observation is corroborated by the changes in the molecular vibrational spectra. The molecular-level mobility measured in the resulting single-phase state of the re-frozen vaccine greatly exceeds the mobility measured in the original vaccine. : Even a brief melting (above 0 °C) leads to an irreversible alteration of the two-phase morphology of the original vaccine formulation. Re-freezing of the vaccine results in a one-phase morphology with much increased molecular-level mobility compared to that in the original vaccine, suggesting irreversible deterioration of the vaccine's in-storage stability. Neutron scattering can be used to distinguish between the vibrational spectra characteristic of the original and deteriorated vaccines contained in the unperturbed original manufacturer-supplied vials.
作为一种基于 mRNA 的疫苗,辉瑞-生物科技公司的 COVID-19 疫苗对保存 mRNA 活性成分的功能有严格的低温储存要求。为此,疫苗配方中的脂质成分在稳定和保护 mRNA 分子的长期储存方面发挥着重要作用。本研究的目的是测量辉瑞-生物科技公司 COVID-19 疫苗中作为温度函数的分子水平动力学,以深入了解其热稳定性。
我们使用准弹性和非弹性中子散射来探测(1)从制造商提供的小瓶中提取的疫苗,以及(2)在原始制造商提供的小瓶中的未受干扰的疫苗。由于中子的高穿透能力,后者的测量成为可能。
从小瓶中取出并从低温冷冻状态升温时,原始形式的疫苗表现出两步融化,表明存在两相形态。一旦融化完成(高于 0°C),疫苗再冷冻就不能恢复其原始的两相状态。这一观察结果得到了分子振动光谱变化的证实。在再冷冻疫苗的单相状态下测量的分子水平迁移率大大超过了原始疫苗中测量的迁移率。
即使是短暂的融化(高于 0°C)也会导致原始疫苗配方的两相形态发生不可逆的改变。疫苗的再冷冻导致单相形态,与原始疫苗相比,分子水平迁移率大大增加,表明疫苗在储存过程中的稳定性发生了不可逆的恶化。中子散射可用于区分未受干扰的原始制造商提供的小瓶中原始和变质疫苗的特征振动光谱。